Cargando…
ADCK1 activates the β-catenin/TCF signaling pathway to promote the growth and migration of colon cancer cells
As a result of mutations in the upstream components of the Wnt/β-catenin signaling pathway, this cascade is abnormally activated in colon cancer. Hence, identifying the activation mechanism of this pathway is an urgent need for the treatment of colon cancer. Here, we found an increase in ADCK1 (AarF...
Autores principales: | Ji, Yong, Liu, Yiqian, Sun, Changchun, Yu, Lijiang, Wang, Zhao, Du, Xu, Yang, Wu, Zhang, Chenggong, Tao, Chunmu, Wang, Jianjiang, Yang, Xi, Di, Sun, Huang, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024291/ https://www.ncbi.nlm.nih.gov/pubmed/33824271 http://dx.doi.org/10.1038/s41419-021-03624-9 |
Ejemplares similares
-
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6
por: Vierthaler, Marlene, et al.
Publicado: (2022) -
Nuclear Dvl, c-Jun, β-catenin, and TCF form a complex leading to stabiLization of β-catenin–TCF interaction
por: Gan, Xiao-qing, et al.
Publicado: (2008) -
ADCK1 is a potential therapeutic target of osteosarcoma
por: Zhuo, Bao-biao, et al.
Publicado: (2022) -
Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC
por: Zhang, Jin-zhi, et al.
Publicado: (2022) -
Drosophila ADCK1 is critical for maintaining mitochondrial structures and functions in the muscle
por: Yoon, Woongchang, et al.
Publicado: (2019)